Ir para o conteúdo
VuFind
  • A sua conta
  • Sair
  • Entrar
  • Idioma
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português (Brasil)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
Avançada
  • Management des Anaphylaxie-Ris...
  • Exemplares
  • Citar
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
    • Exportar para BibTeX
    • Exportar para RIS
  • Adic. favoritos
A carregar...

Código QR

Management des Anaphylaxie-Risikos bei Covid-19-Impfung

Na minha lista:
Detalhes bibliográficos
Publicado no:HNO Nachr
Main Authors: Worm, Margitta, Ring, Johannes, Klimek, Ludger, Jakob, Thilo, Lange, Lars, Treudler, Regina, Beyer, Kirsten, Werfel, Thomas, Biedermann, Tilo, Bircher, Andreas, Fischer, Matthias, Fuchs, Thomas, Heller, Axel R., Hoffmann, Florian, Huttegger, Isidor, Kopp, Matthias Volkmar, Kugler, Claudia, Lommatzsch, Marek, Pfaar, Oliver, Rietschel, Ernst, Ruëff, Franziska, Schnadt, Sabine, Seifert, Roland, Stöcker, Britta, Vogelberg, Christian, Sitter, Helmut, Gieler, Uwe, Brockow, Knut
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Medizin 2021
Assuntos:
Fortbildung
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890774/
https://ncbi.nlm.nih.gov/pubmed/33619418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00060-021-7480-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
  • Exemplares
  • Descrição
  • Comentários
  • Previsualização
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Anaphylaxie-Risiko bei der COVID-19-Impfung: Empfehlungen für das praktische Management
    Por: Worm, Margitta, et al.
    Publicado em: (2021)
  • Leitlinie zu Akuttherapie und Management der Anaphylaxie - Update 2021: S2k-Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbands Deutscher Allergologen (AeDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Deutschen Akademie für Allergologie und Umweltmedizin (DAAU), des Berufsverbands der Kinder- und Jugendärzte (BVKJ), der Gesellschaft für Neonatologie und Pädiatrische Intensivmedizin (GNPI), der Deutschen Dermatologischen Gesellschaft (DDG), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI), der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI), der Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI), der Deutschen Gesellschaft für Pharmakologie (DGP), der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP), der Patientenorganisation Deutscher Allergie- und Asthmabund (DAAB) und der Arbeitsgemeinschaft Anaphylaxie - Training und Edukation (AGATE)
    Por: Ring, Johannes, et al.
    Publicado em: (2021)
  • Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE)
    Por: Ring, Johannes, et al.
    Publicado em: (2021)
  • Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB)
    Por: Ring, Johannes, et al.
    Publicado em: (2014)
  • Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
    Por: Oliver Pfaar, et al.
    Publicado em: (2022-03-01)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs
A carregar...